PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT, USA.\', \'Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.\', \'Department of Genetics, Yale University School of Medicine, New Haven, CT, USA.\', \'Systems Biology Institute, Yale University, West Haven, CT, USA.\', \'Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA.\', \'Serimmune Inc., Goleta, CA, USA.\', \'Institute for Protein Design, University of Washington, Seattle, WA, USA.\', \'Center for Immunity and Inflammation, Rutgers New Jersey Medical School, Newark, NJ, USA.\', \'Department of Pathology, University of Massachusetts Medical School, Worcester, MA, USA.\', \'Howard Hughes Medical Institute, Chevy Chase, MD, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1126/sciimmunol.abl5652
?:doi
?:hasPublicationType
?:journal
  • Science immunology
is ?:pmid of
?:pmid
?:pmid
  • 34914544
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cells.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all